Quantcha now offering unlimited commission-free options trading. Quantchabot has detected a promising Short Risk Reversal trade opportunity for BIOXCEL THERAPEUTICS INC. COMMON STOCK (BTAI) for the 20-Nov-2020 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine. BTAI was recently trading at $54.94 and has an implied volatility of 108.36% for this period. Based on an analysis of the options available for BTAI expiring on 20-Nov-2020, there is a 34.13% likelihood that the underlying will close within the analyzed range of $46.15-$54.94 at expiration. In this scenario, the average linear return for the trade would be 23.34%. Trending on StockTwits: StockTwits® is a financial communications platform for the financial and investing community. On their site, BIOXCEL THERAPEUTICS INC. COMMON STOCK was recently trending, indicating that breaking news and/or market activity has significantly impacted sentiment toward the stock. This movement can be interpretted as a sign of more near-term price movement for the underlying. Trade approach: The recent sentiment change in BTAI on StockTwits appears to be moderately negative, indicating that the stock is likely to follow in that direction for investors trading on sentiment. As a result, a bearish strategy could prove effective if the sentiment ultimately turns out to drive trading. Upside potential: Using this bearish strategy, the trade would be profitable if BIOXCEL THERAPEUTICS INC. COMMON STOCK closed at or below $61.50 on 20-Nov-2020. Based on our analysis, there is a 74.10% likelihood of this return. Downside risk: As with any options trade, there is a substantial downside risk where you may lose most or all of your investment. To analyze this trade in depth, please visit the Quantcha Options Search Engine.